治療用RNAiの世界市場 2020年

• 英文タイトル：Global RNAi for Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115051 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、治療用RNAiの世界市場を調査対象にし、治療用RNAiの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（siRNA、miRNA、shRNA）、用途別分析（がん、循環器、HBV、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Alnylam Pharmaceuticals、Silence Therapeutics、Dicerna Pharmaceuticals、Arbutus Biopharma (Tekmira)、RXi Pharmaceuticals、Arrowhead、miRagen Therapeutics、Quark Pharmaceuticals、Mirna Therapeutics、Benitec Biopharma、Sylentis、Silenseed、Gradalis、Sirnaomics ・企業別売上、市場シェア ・治療用RNAiの地域別市場分析 ・治療用RNAiの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・治療用RNAiのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・治療用RNAiのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・治療用RNAiの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・治療用RNAiの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・治療用RNAiの種類別市場規模2015-2020：siRNA、miRNA、shRNA ・治療用RNAiの用途別市場規模2015-2020：がん、循環器、HBV、その他 ・治療用RNAiの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The RNAi for Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global RNAi for Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 22.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 3480.8 million by 2025, from USD 1565.8 million in 2019.

Market segmentation
RNAi for Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, RNAi for Therapeutic market has been segmented into:
siRNA
miRNA
shRNA

By Application, RNAi for Therapeutic has been segmented into:
Cancer
Cardiovascular
HBV
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RNAi for Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level RNAi for Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RNAi for Therapeutic market.

The report offers in-depth assessment of the growth and other aspects of the RNAi for Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and RNAi for Therapeutic Market Share Analysis
RNAi for Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, RNAi for Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the RNAi for Therapeutic sales, revenue and market share for each player covered in this report.

The major players covered in RNAi for Therapeutic are:
Alnylam Pharmaceuticals
Silence Therapeutics
Dicerna Pharmaceuticals
Arbutus Biopharma (Tekmira)
RXi Pharmaceuticals
Arrowhead
miRagen Therapeutics
Quark Pharmaceuticals
Mirna Therapeutics
Benitec Biopharma
Sylentis
Silenseed
Gradalis
Sirnaomics
Among other players domestic and global, RNAi for Therapeutic market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic by Type
1.2.1 Global RNAi for Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global RNAi for Therapeutic Revenue Market Share by Type in 2019
1.2.3 siRNA
1.2.4 miRNA
1.2.5 shRNA
1.3 Global RNAi for Therapeutic Market by Application
1.3.1 Overview: Global RNAi for Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Global RNAi for Therapeutic Market by Regions
1.4.1 Global RNAi for Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of RNAi for Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) RNAi for Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) RNAi for Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNAi for Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Alnylam Pharmaceuticals Details
2.1.2 Alnylam Pharmaceuticals Major Business
2.1.3 Alnylam Pharmaceuticals SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Product and Services
2.1.5 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Silence Therapeutics
2.2.1 Silence Therapeutics Details
2.2.2 Silence Therapeutics Major Business
2.2.3 Silence Therapeutics SWOT Analysis
2.2.4 Silence Therapeutics Product and Services
2.2.5 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dicerna Pharmaceuticals
2.3.1 Dicerna Pharmaceuticals Details
2.3.2 Dicerna Pharmaceuticals Major Business
2.3.3 Dicerna Pharmaceuticals SWOT Analysis
2.3.4 Dicerna Pharmaceuticals Product and Services
2.3.5 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arbutus Biopharma (Tekmira)
2.4.1 Arbutus Biopharma (Tekmira) Details
2.4.2 Arbutus Biopharma (Tekmira) Major Business
2.4.3 Arbutus Biopharma (Tekmira) SWOT Analysis
2.4.4 Arbutus Biopharma (Tekmira) Product and Services
2.4.5 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 RXi Pharmaceuticals
2.5.1 RXi Pharmaceuticals Details
2.5.2 RXi Pharmaceuticals Major Business
2.5.3 RXi Pharmaceuticals SWOT Analysis
2.5.4 RXi Pharmaceuticals Product and Services
2.5.5 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arrowhead
2.6.1 Arrowhead Details
2.6.2 Arrowhead Major Business
2.6.3 Arrowhead Product and Services
2.6.4 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 miRagen Therapeutics
2.7.1 miRagen Therapeutics Details
2.7.2 miRagen Therapeutics Major Business
2.7.3 miRagen Therapeutics Product and Services
2.7.4 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Quark Pharmaceuticals
2.8.1 Quark Pharmaceuticals Details
2.8.2 Quark Pharmaceuticals Major Business
2.8.3 Quark Pharmaceuticals Product and Services
2.8.4 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mirna Therapeutics
2.9.1 Mirna Therapeutics Details
2.9.2 Mirna Therapeutics Major Business
2.9.3 Mirna Therapeutics Product and Services
2.9.4 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Benitec Biopharma
2.10.1 Benitec Biopharma Details
2.10.2 Benitec Biopharma Major Business
2.10.3 Benitec Biopharma Product and Services
2.10.4 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sylentis
2.11.1 Sylentis Details
2.11.2 Sylentis Major Business
2.11.3 Sylentis Product and Services
2.11.4 Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.12 Silenseed
2.12.1 Silenseed Details
2.12.2 Silenseed Major Business
2.12.3 Silenseed Product and Services
2.12.4 Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.13 Gradalis
2.13.1 Gradalis Details
2.13.2 Gradalis Major Business
2.13.3 Gradalis Product and Services
2.13.4 Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sirnaomics
2.14.1 Sirnaomics Details
2.14.2 Sirnaomics Major Business
2.14.3 Sirnaomics Product and Services
2.14.4 Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global RNAi for Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 RNAi for Therapeutic Players Market Share
3.2.2 Top 10 RNAi for Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global RNAi for Therapeutic Revenue and Market Share by Regions
4.2 North America RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
5 North America RNAi for Therapeutic Revenue by Countries
5.1 North America RNAi for Therapeutic Revenue by Countries (2015-2020)
5.2 USA RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe RNAi for Therapeutic Revenue by Countries
6.1 Europe RNAi for Therapeutic Revenue by Countries (2015-2020)
6.2 Germany RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific RNAi for Therapeutic Revenue by Countries
7.1 Asia-Pacific RNAi for Therapeutic Revenue by Countries (2015-2020)
7.2 China RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
8 South America RNAi for Therapeutic Revenue by Countries
8.1 South America RNAi for Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue RNAi for Therapeutic by Countries
9.1 Middle East & Africa RNAi for Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global RNAi for Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global RNAi for Therapeutic Market Forecast by Type (2019-2024)
10.3 siRNA Revenue Growth Rate (2015-2025)
10.4 miRNA Revenue Growth Rate (2015-2025)
10.5 shRNA Revenue Growth Rate (2015-2025)
11 Global RNAi for Therapeutic Market Segment by Application
11.1 Global RNAi for Therapeutic Revenue Market Share by Application (2015-2020)
11.2 RNAi for Therapeutic Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Cardiovascular Revenue Growth (2015-2020)
11.5 HBV Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global RNAi for Therapeutic Market Size Forecast (2021-2025)
12.1 Global RNAi for Therapeutic Market Size Forecast (2021-2025)
12.2 Global RNAi for Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America RNAi for Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe RNAi for Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America RNAi for Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa RNAi for Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global RNAi for Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of RNAi for Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global RNAi for Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market RNAi for Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global RNAi for Therapeutic Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 7. Alnylam Pharmaceuticals RNAi for Therapeutic Major Business
Table 8. Alnylam Pharmaceuticals RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 9. Alnylam Pharmaceuticals SWOT Analysis
Table 10. Alnylam Pharmaceuticals RNAi for Therapeutic Product and Solutions
Table 11. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Silence Therapeutics Corporate Information, Location and Competitors
Table 13. Silence Therapeutics RNAi for Therapeutic Major Business
Table 14. Silence Therapeutics RNAi for Therapeutic Total Revenue (USD Million) (2018-2019)
Table 15. Silence Therapeutics SWOT Analysis
Table 16. Silence Therapeutics RNAi for Therapeutic Product and Solutions
Table 17. Silence Therapeutics RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Dicerna Pharmaceuticals Corporate Information, Location and Competitors
Table 19. Dicerna Pharmaceuticals RNAi for Therapeutic Major Business
Table 20. Dicerna Pharmaceuticals RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 21. Dicerna Pharmaceuticals SWOT Analysis
Table 22. Dicerna Pharmaceuticals RNAi for Therapeutic Product and Solutions
Table 23. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Arbutus Biopharma (Tekmira) Corporate Information, Location and Competitors
Table 25. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Major Business
Table 26. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 27. Arbutus Biopharma (Tekmira) SWOT Analysis
Table 28. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product and Solutions
Table 29. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. RXi Pharmaceuticals Corporate Information, Location and Competitors
Table 31. RXi Pharmaceuticals RNAi for Therapeutic Major Business
Table 32. RXi Pharmaceuticals RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 33. RXi Pharmaceuticals SWOT Analysis
Table 34. RXi Pharmaceuticals RNAi for Therapeutic Product and Solutions
Table 35. RXi Pharmaceuticals RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Arrowhead Corporate Information, Location and Competitors
Table 37. Arrowhead RNAi for Therapeutic Major Business
Table 38. Arrowhead RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 39. Arrowhead SWOT Analysis
Table 40. Arrowhead RNAi for Therapeutic Product and Solutions
Table 41. Arrowhead RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. miRagen Therapeutics Corporate Information, Location and Competitors
Table 43. miRagen Therapeutics RNAi for Therapeutic Major Business
Table 44. miRagen Therapeutics RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 45. miRagen Therapeutics SWOT Analysis
Table 46. miRagen Therapeutics RNAi for Therapeutic Product and Solutions
Table 47. miRagen Therapeutics RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Quark Pharmaceuticals Corporate Information, Location and Competitors
Table 49. Quark Pharmaceuticals RNAi for Therapeutic Major Business
Table 50. Quark Pharmaceuticals RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 51. Quark Pharmaceuticals SWOT Analysis
Table 52. Quark Pharmaceuticals RNAi for Therapeutic Product and Solutions
Table 53. Quark Pharmaceuticals RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Mirna Therapeutics Corporate Information, Location and Competitors
Table 55. Mirna Therapeutics RNAi for Therapeutic Major Business
Table 56. Mirna Therapeutics RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 57. Mirna Therapeutics SWOT Analysis
Table 58. Mirna Therapeutics RNAi for Therapeutic Product and Solutions
Table 59. Mirna Therapeutics RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Benitec Biopharma Corporate Information, Location and Competitors
Table 61. Benitec Biopharma RNAi for Therapeutic Major Business
Table 62. Benitec Biopharma RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 63. Benitec Biopharma SWOT Analysis
Table 64. Benitec Biopharma RNAi for Therapeutic Product and Solutions
Table 65. Benitec Biopharma RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Sylentis Corporate Information, Location and Competitors
Table 67. Sylentis RNAi for Therapeutic Major Business
Table 68. Sylentis RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 69. Sylentis SWOT Analysis
Table 70. Sylentis RNAi for Therapeutic Product and Solutions
Table 71. Sylentis RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Silenseed Corporate Information, Location and Competitors
Table 73. Silenseed RNAi for Therapeutic Major Business
Table 74. Silenseed RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 75. Silenseed SWOT Analysis
Table 76. Silenseed RNAi for Therapeutic Product and Solutions
Table 77. Silenseed RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Gradalis Corporate Information, Location and Competitors
Table 79. Gradalis RNAi for Therapeutic Major Business
Table 80. Gradalis RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 81. Gradalis SWOT Analysis
Table 82. Gradalis RNAi for Therapeutic Product and Solutions
Table 83. Gradalis RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Sirnaomics Corporate Information, Location and Competitors
Table 85. Sirnaomics RNAi for Therapeutic Major Business
Table 86. Sirnaomics RNAi for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 87. Sirnaomics SWOT Analysis
Table 88. Sirnaomics RNAi for Therapeutic Product and Solutions
Table 89. Sirnaomics RNAi for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global RNAi for Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 91. Global RNAi for Therapeutic Revenue Share by Players (2015-2020)
Table 92. Global RNAi for Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 93. Global RNAi for Therapeutic Revenue Market Share by Regions (2015-2020)
Table 94. North America RNAi for Therapeutic Revenue by Countries (2015-2020)
Table 95. North America RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 96. Europe RNAi for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific RNAi for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 98. South America RNAi for Therapeutic Revenue by Countries (2015-2020)
Table 99. South America RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa RNAi for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 102. Global RNAi for Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 103. Global RNAi for Therapeutic Revenue Share by Type (2015-2020)
Table 104. Global RNAi for Therapeutic Revenue Forecast by Type (2021-2025)
Table 105. Global RNAi for Therapeutic Revenue by Application (2015-2020)
Table 106. Global RNAi for Therapeutic Revenue Share by Application (2015-2020)
Table 107. Global RNAi for Therapeutic Revenue Forecast by Application (2021-2025)
Table 108. Global RNAi for Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. RNAi for Therapeutic Picture
Figure 2. Global RNAi for Therapeutic Revenue Market Share by Type in 2019
Figure 3. siRNA Picture
Figure 4. miRNA Picture
Figure 5. shRNA Picture
Figure 6. RNAi for Therapeutic Revenue Market Share by Application in 2019
Figure 7. Cancer Picture
Figure 8. Cardiovascular Picture
Figure 9. HBV Picture
Figure 10. Other Picture
Figure 11. Global RNAi for Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global RNAi for Therapeutic Revenue Share by Players in 2019
Figure 19. Global Top 5 Players RNAi for Therapeutic Revenue Market Share in 2019
Figure 20. Global Top 10 Players RNAi for Therapeutic Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global RNAi for Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 24. Global RNAi for Therapeutic Revenue Market Share by Regions in 2018
Figure 25. North America RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 26. Europe RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. South America RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. North America RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 31. North America RNAi for Therapeutic Revenue Market Share by Countries in 2019
Figure 32. USA RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 33. Canada RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 34. Mexico RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Europe RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 36. Europe RNAi for Therapeutic Revenue Market Share by Countries in 2019
Figure 37. Germany RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 38. UK RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. France RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. Russia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. Italy RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries in 2019
Figure 44. China RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 45. Japan RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Korea RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. India RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. South America RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 50. South America RNAi for Therapeutic Revenue Market Share by Countries in 2019
Figure 51. Brazil RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 52. Argentina RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 56. UAE RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. Egypt RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. South Africa RNAi for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. Global RNAi for Therapeutic Revenue Share by Type (2015-2020)
Figure 60. Global RNAi for Therapeutic Revenue Share by Type in 2019
Figure 61. Global RNAi for Therapeutic Market Share Forecast by Type (2021-2025)
Figure 62. Global siRNA Revenue Growth Rate (2015-2020)
Figure 63. Global miRNA Revenue Growth Rate (2015-2020)
Figure 64. Global shRNA Revenue Growth Rate (2015-2020)
Figure 65. Global RNAi for Therapeutic Revenue Share by Application (2015-2020)
Figure 66. Global RNAi for Therapeutic Revenue Share by Application in 2019
Figure 67. Global RNAi for Therapeutic Market Share Forecast by Application (2021-2025)
Figure 68. Global Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 70. Global HBV Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global RNAi for Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global RNAi for Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America RNAi for Therapeutic Revenue Market Forecast (2021-2025)
Figure 76. Europe RNAi for Therapeutic Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2021-2025)
Figure 78. South America RNAi for Therapeutic Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa RNAi for Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---